Literature DB >> 15858144

Molecular classification of renal tumors by gene expression profiling.

Audrey N Schuetz1, Qiqin Yin-Goen, Mahul B Amin, Carlos S Moreno, Cynthia Cohen, Christopher D Hornsby, Wen Li Yang, John A Petros, Muta M Issa, John G Pattaras, Kenneth Ogan, Fray F Marshall, Andrew N Young.   

Abstract

Renal tumor classification is important because histopathological subtypes are associated with distinct clinical behavior. However, diagnosis is difficult because tumor subtypes have overlapping microscopic characteristics. Therefore, ancillary methods are needed to optimize classification. We used oligonucleotide microarrays to analyze 31 adult renal tumors, including clear cell renal cell carcinoma (RCC), papillary RCC, chromophobe RCC, oncocytoma, and angiomyolipoma. Expression profiles correlated with histopathology; unsupervised algorithms clustered 30 of 31 tumors according to appropriate diagnostic subtypes while supervised analyses identified significant, subtype-specific expression markers. Clear cell RCC overexpressed proximal nephron, angiogenic, and immune response genes, chromophobe RCC oncocytoma overexpressed distal nephron and oxidative phosphorylation genes, papillary RCC overexpressed serine protease inhibitors, and extracellular matrix products, and angiomyolipoma overexpressed muscle developmental, lipid biosynthetic, melanocytic, and distinct angiogenic factors. Quantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry of formalin-fixed renal tumors confirmed overexpression of proximal nephron markers (megalin/low-density lipoprotein-related protein 2, alpha-methylacyl CoA racemase) in clear cell and papillary RCC and distal nephron markers (beta-defensin 1, claudin 7) in chromophobe RCC/oncocytoma. In summary, renal tumor subtypes were classified by distinct gene expression profiles, illustrating tumor pathobiology and translating into novel molecular bioassays using fixed tissue.

Entities:  

Mesh:

Year:  2005        PMID: 15858144      PMCID: PMC1867531          DOI: 10.1016/S1525-1578(10)60547-8

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  72 in total

1.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

2.  Angiomyolipoma of kidney as a part of tuberous sclerosis complex.

Authors:  C H Chen; C C Tzeng; T C Cheng; A W Chiu
Journal:  J Postgrad Med       Date:  2003 Jul-Sep       Impact factor: 1.476

Review 3.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

4.  Expression of claudin-7 and -8 along the mouse nephron.

Authors:  Wing Y Li; Catherine L Huey; Alan S L Yu
Journal:  Am J Physiol Renal Physiol       Date:  2004-01-13

Review 5.  TSC2: filling the GAP in the mTOR signaling pathway.

Authors:  Yong Li; Michael N Corradetti; Ken Inoki; Kun-Liang Guan
Journal:  Trends Biochem Sci       Date:  2004-01       Impact factor: 13.807

6.  Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays.

Authors:  Andrew N Young; Paulo G de Oliveira Salles; So Dug Lim; Cynthia Cohen; John A Petros; Fray F Marshall; Andrew S Neish; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2003-02       Impact factor: 6.394

7.  Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma.

Authors:  Maria S Tretiakova; Sunati Sahoo; Masayuki Takahashi; Muge Turkyilmaz; Nicholas J Vogelzang; Fan Lin; Thomas Krausz; Bin Tean Teh; Ximing J Yang
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394

8.  Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.

Authors:  Stephen D W Beck; Manish I Patel; Mark E Snyder; Michael W Kattan; Robert J Motzer; Victor E Reuter; Paul Russo
Journal:  Ann Surg Oncol       Date:  2004-01       Impact factor: 5.344

Review 9.  Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.

Authors:  Allan J Pantuck; Gang Zeng; Arie S Belldegrun; Robert A Figlin
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

10.  Expression profiling of human renal carcinomas with functional taxonomic analysis.

Authors:  Michael A Gieseg; Theresa Cody; Michael Z Man; Steven J Madore; Mark A Rubin; Eric P Kaldjian
Journal:  BMC Bioinformatics       Date:  2002-09-30       Impact factor: 3.169

View more
  43 in total

Review 1.  Renal cell carcinoma deep sequencing: recent developments.

Authors:  Leslie J Farber; Kyle Furge; Bin Tean Teh
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

2.  Combining multiple microarray studies using bootstrap meta-analysis.

Authors:  Andrea B Barrett; John H Phan; May D Wang
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2008

3.  Emerging translational bioinformatics: knowledge-guided biomarker identification for cancer diagnostics.

Authors:  John H Phan; Qiqin Yin-Goen; Andrew N Young; May D Wang
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

4.  Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.

Authors:  Min-Han Tan; Chin Fong Wong; Hwei Ling Tan; Ximing J Yang; Jonathon Ditlev; Daisuke Matsuda; Sok Kean Khoo; Jun Sugimura; Tomoaki Fujioka; Kyle A Furge; Eric Kort; Sophie Giraud; Sophie Ferlicot; Philippe Vielh; Delphine Amsellem-Ouazana; Bernard Debré; Thierry Flam; Nicolas Thiounn; Marc Zerbib; Gérard Benoît; Stéphane Droupy; Vincent Molinié; Annick Vieillefond; Puay Hoon Tan; Stéphane Richard; Bin Tean Teh
Journal:  BMC Cancer       Date:  2010-05-12       Impact factor: 4.430

5.  Pathway signature and cellular differentiation in clear cell renal cell carcinoma.

Authors:  Han W Tun; Laura A Marlow; Christina A von Roemeling; Simon J Cooper; Pamela Kreinest; Kevin Wu; Bruce A Luxon; Mala Sinha; Panos Z Anastasiadis; John A Copland
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

6.  Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up.

Authors:  Marie Dvorakova; Rajiv Dhir; Sheldon I Bastacky; Kathleen M Cieply; Marie B Acquafondata; Carol R Sherer; Tracy L Mercuri; Anil V Parwani
Journal:  Diagn Pathol       Date:  2010-05-24       Impact factor: 2.644

7.  Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.

Authors:  Hisashi Hasumi; Masaya Baba; Yukiko Hasumi; Ying Huang; Hyoungbin Oh; Robert M Hughes; Mara E Klein; Shoichi Takikita; Kunio Nagashima; Laura S Schmidt; W Marston Linehan
Journal:  J Natl Cancer Inst       Date:  2012-11-12       Impact factor: 13.506

8.  High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas.

Authors:  Maria V Yusenko; Roland P Kuiper; Tamas Boethe; Börje Ljungberg; Ad Geurts van Kessel; Gyula Kovacs
Journal:  BMC Cancer       Date:  2009-05-18       Impact factor: 4.430

9.  Gene expression profiling of chromophobe renal cell carcinomas and renal oncocytomas by Affymetrix GeneChip using pooled and individual tumours.

Authors:  Maria V Yusenko; Dmitry Zubakov; Gyula Kovacs
Journal:  Int J Biol Sci       Date:  2009-07-29       Impact factor: 6.580

10.  CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma.

Authors:  Ariel A Williams; John P T Higgins; Hongjuan Zhao; Börje Ljunberg; James D Brooks
Journal:  BMC Clin Pathol       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.